Clinical Trial Update: Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of ENV515 Travoprost Extended Release (XR) in patients with Bilateral Ocular Hypertension or Primary Open-Angle Glau…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• ENV515 Travoprost Extended Release (XR) (travoprost extended-release)

Snippet

Sponsor: Envisia Therapeutics | Conditions: Glaucoma and Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-10-17